Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Y-mAbs Therapeutics

    Client Virtual Booth

    Y-MABS THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Y-mAbs Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    230 Park Avenue, Suite 3350 New York, NY 10169
    Telephone
    Telephone
    +1 646 885 8505
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ymabs.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Y-mAbs Therapeutics Naxitamab-gqgk Receives Suppl Approval in the U.S
    Y-mAbs Therapeutics Naxitamab-gqgk Receives Suppl Approval in the U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761171

    FDA
    20 Mar 2024
    Share Share
    Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
    Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer

    https://www.globenewswire.com//news-release/2024/03/14/2846337/0/en/Y-mAbs-Therapeutics-Announces-Resignation-of-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    14 Mar 2024
    Share Share
    Y-mAbs Appoints Executive Mary Tagliaferri, M.D. to its Board of Directors
    Y-mAbs Appoints Executive Mary Tagliaferri, M.D. to its Board of Directors

    https://www.globenewswire.com//news-release/2024/03/04/2839442/0/en/Y-mAbs-Appoints-Oncology-Executive-Mary-Tagliaferri-M-D-to-its-Board-of-Directors.html

    GLOBENEWSWIRE
    04 Mar 2024
    Share Share
    Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results
    Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/29/2838407/0/en/Y-mAbs-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    29 Feb 2024
    Share Share
    Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial Results
    Y-mAbs to Announce Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/02/16/2830703/0/en/Y-mAbs-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-and-Operating-Results-on-February-29-2024.html

    GLOBENEWSWIRE
    16 Feb 2024
    Share Share
    Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
    Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

    https://www.globenewswire.com//news-release/2024/01/02/2802924/0/en/Y-mAbs-Therapeutics-to-Present-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    02 Jan 2024
    Share Share
    Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
    Y-mAbs Therapeutics Added to the NASDAQ Biotechnology Index

    https://www.globenewswire.com//news-release/2023/12/13/2795869/0/en/Y-mAbs-Therapeutics-Added-to-the-NASDAQ-Biotechnology-Index.html

    GLOBENEWSWIRE
    13 Dec 2023
    Share Share
    Y-mAbs Reports Third Quarter 2023 Financial Results
    Y-mAbs Reports Third Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2023/11/13/2779460/0/en/Y-mAbs-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    13 Nov 2023
    Share Share
    Y-mAbs to Announce Third Quarter 2023 Financial and Operating Results
    Y-mAbs to Announce Third Quarter 2023 Financial and Operating Results

    https://www.globenewswire.com//news-release/2023/10/31/2770021/0/en/Y-mAbs-to-Announce-Third-Quarter-2023-Financial-and-Operating-Results-on-November-13-2023.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director
    Y-mAbs Names Michael Rossi as President and Chief Executive Officer and Director

    https://www.globenewswire.com//news-release/2023/10/18/2762734/0/en/Y-mAbs-Names-Michael-Rossi-as-President-and-Chief-Executive-Officer-and-Director.html

    GLOBENEWSWIRE
    18 Oct 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search